Disc Medicine is laying off about 20% of its workforce after the Food and Drug Administration denied its application for accelerated approval of its bitopertin treatment.
In the first couple of months of 2026, the artificial disc landscape is shaking up with developments in the technology, new adoption and research. 1. Armen Khachatryan, MD, performed the first U.S.
Members of the Leadership Clinton Class of 2026 met recently at the Ohio Living Cape May Community Room for a leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results